It does not engage the GIP receptor (Tirzepatide's second target) or the Glucagon receptor (Retatrutide's third target)
Efectos Adversos Aunque los anlogos de GLP-1 proporcionan muchos beneficios, se asocian con efectos secundarios, principalmente sntomas gastrointestinales como nuseas (25%-50%), vmitos (10%-15%), diarrea (8%-15%) y estreimiento
Maretty L, Gill D, Simonsen L, Soh K, Zagkos L, Galanakis M, Sibbesen J, Iglesias MT, Secher A, Valkenborg D, Purnell JQ, Knudsen LB, Tahrani AA, Geybels M (2025) Proteomic changes upon treatment with semaglutide in individuals with obesity
A&A Case Reports
A subsequent study examined ultraviolet exposure parameters across similarly distributed cohorts, followed by a third trial employing an equal peptide placebo allocation